simvastatin has been researched along with Di Guglielmo Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Griner, LN; Johnson, JO; List, AF; McGraw, KL; Reuther, GW | 1 |
1 other study(ies) available for simvastatin and Di Guglielmo Disease
Article | Year |
---|---|
JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth.
Topics: Apoptosis; beta-Cyclodextrins; Cell Line, Tumor; Cells, Cultured; Cholesterol; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Erythroid Precursor Cells; Humans; Janus Kinase 2; K562 Cells; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Megakaryocyte Progenitor Cells; Membrane Lipids; Membrane Microdomains; Mutation, Missense; Myeloproliferative Disorders; Phosphorylation; Point Mutation; Protein Processing, Post-Translational; Signal Transduction; Simvastatin; STAT5 Transcription Factor | 2013 |